JP2010166921A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010166921A5 JP2010166921A5 JP2010044336A JP2010044336A JP2010166921A5 JP 2010166921 A5 JP2010166921 A5 JP 2010166921A5 JP 2010044336 A JP2010044336 A JP 2010044336A JP 2010044336 A JP2010044336 A JP 2010044336A JP 2010166921 A5 JP2010166921 A5 JP 2010166921A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 108091033319 polynucleotide Proteins 0.000 claims 18
- 239000002157 polynucleotide Substances 0.000 claims 18
- 102000040430 polynucleotide Human genes 0.000 claims 18
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 14
- 239000002773 nucleotide Substances 0.000 claims 12
- 125000003729 nucleotide group Chemical group 0.000 claims 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- 208000034762 Meningococcal Infections Diseases 0.000 claims 2
- 241000588650 Neisseria meningitidis Species 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000000523 sample Substances 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000001768 subcellular fraction Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810276.7A GB9810276D0 (en) | 1998-05-13 | 1998-05-13 | Novel compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Division JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010166921A JP2010166921A (ja) | 2010-08-05 |
| JP2010166921A5 true JP2010166921A5 (enExample) | 2011-07-28 |
Family
ID=10831992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Expired - Fee Related JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
| JP2010044336A Pending JP2010166921A (ja) | 1998-05-13 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548474A Expired - Fee Related JP4707832B2 (ja) | 1998-05-13 | 1999-05-07 | 髄膜炎菌由来のｂａｓｂ０２９ポリヌクレオチドおよびポリペプチド |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6780419B1 (enExample) |
| EP (2) | EP1621623A3 (enExample) |
| JP (2) | JP4707832B2 (enExample) |
| KR (4) | KR20100019461A (enExample) |
| CN (1) | CN1322127C (enExample) |
| AT (1) | ATE311457T1 (enExample) |
| AU (1) | AU750032B2 (enExample) |
| BR (1) | BR9910396A (enExample) |
| CA (1) | CA2328403C (enExample) |
| CY (1) | CY1105676T1 (enExample) |
| CZ (1) | CZ299612B6 (enExample) |
| DE (1) | DE69928658T2 (enExample) |
| DK (1) | DK1078063T3 (enExample) |
| ES (1) | ES2252946T3 (enExample) |
| GB (1) | GB9810276D0 (enExample) |
| HU (1) | HUP0102479A3 (enExample) |
| IL (2) | IL139613A0 (enExample) |
| NO (2) | NO326994B1 (enExample) |
| NZ (1) | NZ508323A (enExample) |
| PL (1) | PL197449B1 (enExample) |
| TR (1) | TR200003347T2 (enExample) |
| WO (1) | WO1999058683A2 (enExample) |
| ZA (1) | ZA200006523B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| SG152917A1 (en) * | 1998-01-14 | 2009-06-29 | Chiron Srl | Neisseria meningitidis antigens |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| ATE279943T1 (de) | 1999-02-26 | 2004-11-15 | Chiron Srl | Verbesserung der bakterizidaktivität von neisseria antigenen mit cg enthaltende oligonukleotiden |
| GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| EP2275553B1 (en) | 1999-10-29 | 2015-05-13 | Novartis Vaccines and Diagnostics S.r.l. | Neisserial antigenic peptides |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| CA2871789C (en) | 2000-01-17 | 2017-04-04 | Novartis Vaccines And Diagnostics S.R.L. | Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| ES2389719T3 (es) * | 2000-01-25 | 2012-10-30 | The University Of Queensland | Proteínas que comprenden regiones conservadas del antígeno de superficie de Neisseria meningitidis NhhA |
| JP4763210B2 (ja) | 2000-02-28 | 2011-08-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | ナイセリアのタンパク質の異種発現 |
| US20050232936A1 (en) | 2001-07-27 | 2005-10-20 | Chiron Corporation | Meningococcus adhesins nada, app and orf 40 |
| CA2489030A1 (en) | 2002-08-02 | 2004-02-19 | Glaxosmithkline Biologicals S.A. | Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| MXPA05003863A (es) | 2002-10-11 | 2005-09-08 | Chiron Srl | Vacunas polipeptidicas para amplia proteccion contra lineas hipervirulentas de meningococos. |
| ES2397923T3 (es) | 2003-10-02 | 2013-03-12 | Novartis Ag | Vacunas líquidas para múltiples serogrupos meningocócicos |
| US7459930B2 (en) * | 2006-11-14 | 2008-12-02 | Micron Technology, Inc. | Digital calibration circuits, devices and systems including same, and methods of operation |
| GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
| GB0916570D0 (en) | 2009-09-21 | 2009-10-28 | Royal Holloway & Bedford New C | Method |
| US9365624B2 (en) | 2010-03-11 | 2016-06-14 | Glaxosmithkline Biologicals, S.A. | Vaccine |
| CA2859078A1 (en) * | 2012-01-05 | 2013-07-11 | Deutsches Krebsforschungszentrum | Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers |
| AU2016416450B2 (en) | 2016-07-27 | 2021-08-12 | Prysmian S.P.A. | Flexible optical-fiber ribbon |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4769240A (en) * | 1980-09-15 | 1988-09-06 | Bactex, Inc. | Pili of neisseria and vaccine compositions containing same |
| US4702911A (en) * | 1985-09-27 | 1987-10-27 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
| RU2023448C1 (ru) * | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
| FR2682041B1 (fr) * | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
| US6245337B1 (en) * | 1994-08-25 | 2001-06-12 | Washington University | Haemophilus adherence and penetration proteins |
| US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
| US5646259A (en) * | 1995-03-24 | 1997-07-08 | St. Louis University | DNA encoding haemophilus adhesion proteins |
| US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
| CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| SG152917A1 (en) * | 1998-01-14 | 2009-06-29 | Chiron Srl | Neisseria meningitidis antigens |
| GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| NZ530640A (en) * | 1999-04-30 | 2006-06-30 | Chiron S | Conserved neisserial antigens |
-
1998
- 1998-05-13 GB GBGB9810276.7A patent/GB9810276D0/en not_active Ceased
-
1999
- 1999-05-07 EP EP20050077297 patent/EP1621623A3/en not_active Withdrawn
- 1999-05-07 BR BR9910396-6A patent/BR9910396A/pt not_active Application Discontinuation
- 1999-05-07 CA CA2328403A patent/CA2328403C/en not_active Expired - Fee Related
- 1999-05-07 CN CNB998086061A patent/CN1322127C/zh not_active Expired - Fee Related
- 1999-05-07 KR KR1020097024661A patent/KR20100019461A/ko not_active Ceased
- 1999-05-07 NZ NZ508323A patent/NZ508323A/xx not_active IP Right Cessation
- 1999-05-07 IL IL13961399A patent/IL139613A0/xx unknown
- 1999-05-07 KR KR1020087014761A patent/KR20080070073A/ko not_active Ceased
- 1999-05-07 WO PCT/EP1999/003255 patent/WO1999058683A2/en not_active Ceased
- 1999-05-07 PL PL345281A patent/PL197449B1/pl not_active IP Right Cessation
- 1999-05-07 JP JP2000548474A patent/JP4707832B2/ja not_active Expired - Fee Related
- 1999-05-07 CZ CZ20004202A patent/CZ299612B6/cs not_active IP Right Cessation
- 1999-05-07 US US09/700,293 patent/US6780419B1/en not_active Expired - Lifetime
- 1999-05-07 DK DK99924946T patent/DK1078063T3/da active
- 1999-05-07 DE DE69928658T patent/DE69928658T2/de not_active Expired - Lifetime
- 1999-05-07 EP EP99924946A patent/EP1078063B1/en not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03347T patent/TR200003347T2/xx unknown
- 1999-05-07 AU AU41420/99A patent/AU750032B2/en not_active Ceased
- 1999-05-07 KR KR1020067009829A patent/KR100897951B1/ko not_active Expired - Fee Related
- 1999-05-07 ES ES99924946T patent/ES2252946T3/es not_active Expired - Lifetime
- 1999-05-07 AT AT99924946T patent/ATE311457T1/de active
- 1999-05-07 KR KR1020007012700A patent/KR100673674B1/ko not_active Expired - Fee Related
- 1999-05-07 HU HU0102479A patent/HUP0102479A3/hu unknown
-
2000
- 2000-11-10 IL IL139613A patent/IL139613A/en not_active IP Right Cessation
- 2000-11-10 NO NO20005696A patent/NO326994B1/no not_active IP Right Cessation
- 2000-11-10 ZA ZA200006523A patent/ZA200006523B/xx unknown
-
2004
- 2004-07-22 US US10/896,778 patent/US20040265332A1/en not_active Abandoned
-
2006
- 2006-01-17 CY CY20061100057T patent/CY1105676T1/el unknown
-
2007
- 2007-12-07 US US11/999,978 patent/US20090093622A1/en not_active Abandoned
-
2009
- 2009-03-02 NO NO20090955A patent/NO20090955L/no not_active Application Discontinuation
-
2010
- 2010-03-01 JP JP2010044336A patent/JP2010166921A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010166921A5 (enExample) | ||
| CN102675471B (zh) | 猪口蹄疫病毒o型广谱多表位重组抗原及其应用 | |
| RU2012155702A (ru) | Композиция микробактериальных антигенов | |
| JP2010162023A5 (enExample) | ||
| CN103007273B (zh) | 一种口蹄疫基因工程混合表位疫苗及其制备方法 | |
| CN107432930B (zh) | 一种i群4型禽腺病毒dna疫苗及其制备方法和应用 | |
| CN101289496B (zh) | 能激发机体抗结核杆菌的保护性免疫反应的抗原表位筛选方法及用途 | |
| CN113150084B (zh) | 一种纳米化的冠状病毒抗原及其应用 | |
| JP2025183322A (ja) | プロピオニバクテリウム・アクネスの予防的かつ治療的な免疫処置 | |
| KR101919002B1 (ko) | 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도 | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| WO2020238458A1 (zh) | 用于表达e2蛋白的细胞株及其应用，e2蛋白及其应用 | |
| CN106146626B (zh) | 一种红斑丹毒丝菌亚单位疫苗及制备方法及应用 | |
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| EP3254693A1 (en) | Lactic-acid-bacteria-containing composition, oral pharmaceutical composition for treating hpv infection and/or hpv-associated tumors, and mucosal immunity-inducing agent | |
| JP2010535504A5 (enExample) | ||
| JP2014502143A5 (enExample) | ||
| CN103539839A (zh) | 肠道病毒71型的vp2抗原的中和表位多肽及其用途 | |
| CN108330142B (zh) | 一种具有免疫保护作用的美人鱼发光杆菌溶血素Hlych蛋白 | |
| CN106226520B (zh) | 结核分枝杆菌抗原蛋白Rv0865及其B细胞表位肽的应用 | |
| CN116621971B (zh) | Hpv18亚型的纳米抗体及其应用 | |
| CN103352047A (zh) | 旋毛虫肌幼虫es抗原基因疫苗及其制备方法 | |
| CN102657864A (zh) | 一种口蹄疫疫苗的免疫佐剂及其应用 | |
| RU2013135002A (ru) | Вакцинный антиген бабезиоза собак | |
| CN116621970B (zh) | Hpv16亚型的纳米抗体及其应用 |